Sysmed Exim Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 4.47 Cr
as on 24-10-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 159.21 Cr
as on 24-10-2024
- Satisfied Charges ₹ 22.20 Cr
as on 24-10-2024
- Revenue 212.50%
(FY 2023)
- Profit 642.13%
(FY 2023)
- Ebitda 557.11%
(FY 2023)
- Net Worth 100.58%
(FY 2023)
- Total Assets 100.68%
(FY 2023)
About Sysmed Exim
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.47 Cr.
The company currently has active open charges totaling ₹159.21 Cr. The company has closed loans amounting to ₹22.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Veena Jolly, Ankur Mangla, Chander Jolly, and One other member serve as directors at the Company.
- CIN/LLPIN
U51900PB2014PTC038818
- Company No.
038818
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Mohali, Punjab, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sysmed Exim Private Limited offer?
Sysmed Exim Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Syringes, Forceps & Graspers, Surgical Clamps, Medical Tubes, Surgical & Medical Consumables, Surgical Disposables, Disposable Syringe, Disposable Cannulas, Cosmetics, Hair & Beauty Products.
Who are the key members and board of directors at Sysmed Exim?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankur Mangla  | Managing Director | 07-Aug-2014 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Veena Jolly | Director | 07-Aug-2014 | Current |
| Chander Jolly | Director | 10-May-2021 | Current |
| Vaibhav Mangla | Director | 21-Dec-2022 | Current |
Financial Performance and Corporate Structure Insights of Sysmed Exim.
Sysmed Exim Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 212.5% increase. The company also saw a substantial improvement in profitability, with a 642.13% increase in profit. The company's net worth Soared by an impressive increase of 100.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sysmed Exim?
In 2023, Sysmed Exim had a promoter holding of 89.36% and a public holding of 10.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sysmed Medical Technologies Private LimitedActive 1 year 8 months
Veena Jolly and Ankur Mangla are mutual person
- Sysmed Poct Private LimitedActive 4 years 11 months
Veena Jolly, Ankur Mangla and 1 more are mutual person
- Sysmed Infra Private LimitedActive 5 years 1 month
Veena Jolly, Ankur Mangla and 1 more are mutual person
- Ram Joginder Rai Charitable Helpage CouncilActive 5 years 7 months
Veena Jolly and Chander Jolly are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 26 May 2023 | ₹1.09 Cr | Open |
Hdfc Bank Limited Creation Date: 22 Mar 2023 | ₹110.00 Cr | Open |
Axis Bank Limited Creation Date: 17 Mar 2023 | ₹9.00 M | Open |
How Many Employees Work at Sysmed Exim?
Sysmed Exim has a workforce of 57 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sysmed Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sysmed Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
